GSK3B, glycogen synthase kinase 3 beta, 2932

N. diseases: 393; N. variants: 25
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Biomarker disease BEFREE Stilbenoid pterostilbene complexed with cyclodextrin preserves left ventricular function after myocardial infarction in rats: possible involvement of thiol proteins and modulation of phosphorylated GSK-3β. 30203709 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 PosttranslationalModification disease BEFREE Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction. 29940198 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 PosttranslationalModification disease BEFREE Eplerenone attenuates myocardial infarction in diabetic rats via modulation of the PI3K-Akt pathway and phosphorylation of GSK-3β. 30323868 2018
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Biomarker disease BEFREE Moreover, expressions of p-Akt/Akt and p-GSK-3β/GSK-3β in the myocardium of MI group rats were significantly increased by nesfatin-1 administration, suggesting that nesfatin-1, which appears to possess anti-apoptotic and anti-inflammatory properties, may confer protection against ISO-induced MI via an Akt/GSK-3β-dependent mechanism. 28720397 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Biomarker disease BEFREE We assessed whether n-butylidenephthalide (BP) primed ADSCs can attenuate arrhythmias by a GSK-3β-dependent pathway after myocardial infarction. 28130118 2017
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Biomarker disease BEFREE Deletion of GSK-3β induces a profibrotic myofibroblast phenotype in isolated cardiac fibroblasts, in post-myocardial infarction hearts, and in mouse embryonic fibroblasts deleted for GSK-3β. 24899689 2014
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Therapeutic disease RGD Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. 16565311 2006
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.560 Biomarker disease CTD_human PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. 16716347 2006